The content is not intended to be a substitute for professional medical advice, diagnosis or treatment. We strongly advise all users with health problems to consult a doctor who will be able to provide a proper diagnosis based on a knowledge and understanding of your medical history and all aspects of your symptoms. Never disregard professional medical advice, or delay in seeking it, because of something you have read on this web site. Never rely on information on this web site in place of seeking professional medical advice.
Our products are not approved by the Food and Drug Administration (FDA) and may not be used to diagnose, treat, or prevent any disease. Due to the limited amount of clinical evidence regarding hemp-derived extracts in treating disease states, we cannot offer any type of comment or recommendation. We do, however, recommend you research the National Academies of Science (NAS) publish report regarding the current state of evidence regarding cannabis research: http://nationalacademies.org/hmd/Reports/2017/health-effects-of-cannabis-and-cannabinoids.aspx
Los Angeles-based PureKana stresses that it extracts the CBD oil for its products from hemp plants that have been cultivated without the use of herbicides, pesticides or other agro-industrial chemicals that may impact upon crops. What’s more, the company states, no solvents go into the extraction process other than carbon dioxide. And to further put potential customers’ minds at rest, PureKana presents the results of third-party testing of its CBD oil tincture on its website – a welcome nod to transparency. That tincture can be found in the company’s own blend of CBD oil drops – the three varieties of which have elicited highly complimentary reviews from users – as well as its capsules and cooling topical ointment. Meanwhile, for anyone with a sweet tooth, PureKana’s CBD isolate-containing gummy bears may just do the trick.
CBD products have zero THC content, so you should not be worried about getting high after using them. One group of people that stands to benefits a lot from using them is women. Their bodies are quite different from men, and the chances of putting in extra weight are high. Beauty is another thing that defines most women. Most of them will make good use of different products to enhance their beauty. Different CBD products can be useful to them when it comes to skin care and weight loss.
CBD (cannabidiol) is a Cannabinoid – a molecular compound found in the cannabis plant. There are 85 known cannabinoids and they have a variety of effects on the body, particularly around mood, sleep, anxiety and appetite. The research is largely in its infancy, but so far the overwhelming evidence is that there are a lot of recovery benefits to CBD oil.
I’ve been using their natural oil for about a week now, and I thoroughly enjoy it. Recently, however, I got my wife a small bottle of their mint flavored CBD oil, and she loves it. She never cared for the natural hemp taste. For those of you who are interested, it also comes in a citrus flavor. I had the opportunity to sample that once and was not disappointed.
There are some important points to keep in mind, though. The recent passing of the Agricultural Improvement Act of 2018 changed the classification of hemp from a Schedule I substance to an “agricultural commodity,” paving the way for hemp and hemp-derived substances to be bought and sold legally. It’s also worth pointing out that the DEA recently reclassified some CBD (with a THC content <.0%) from a Schedule I, illegal substance, to the less-restrictive Schedule 5 drugs, as long as an item has been approved by the U.S. Food and Drug Administration. Lastly, the Farm Bill lifted restrictions on sales and transportation, as well as possession of CBD derived from hemp as long as the hemp:
Recently, the Hemp Industries Association joined forces with RMH Holdings and Centuria Natural Food to challenge the law, asking the federal court to review the final rule on the grounds that it is arbitrary and unconstitutional. The opening brief, filed on April 3, 2017, accuses the DEA of failing to act in accordance with standard protocol for scheduling the newly prohibited substance under the Controlled Substances Act.